Showing results (331-340 of 4,206) with videos related to

Sort By:
Pageof 421
Discover Oncology|January 6, 2026
The role of PCMT1 in prognosis tumor immune microenvironment and therapeutic responses across cancersBo Wang, Sijia Huang, Ruizhen Ren, et al.
Discover Oncology|December 25, 2025
Postbiotic-mediated gut microbiome modulation enhances R-CHOP efficacy in high-risk diffuse large B-cell lymphoma: a case reportXiujie Liu, Donghai Cheng, Fangyan Wang
Discover Oncology|December 22, 2025
Lactylation-related lncRNAs can forecast prognosis and immune response of lung adenocarcinomaLe Zhou, Zhongjiang Lan, Bo Han, et al.
Discover Oncology|August 22, 2025
CAR-T cell therapy in china: innovations, challenges, and strategic pathwaysLihui Yan, Boshi Duan, Peng Sun, et al.
Discover Oncology|August 22, 2025
The landscape of research on B cell and immunotherapy in solid tumors over the past 20 yearsShuman Kuang, Mingjian Piao, Chengjie Li, et al.
Discover Oncology|August 22, 2025
Identification of endothelial INSR as an osteosarcoma-related biomarker and therapeutic target based on weighted gene co-expression network analysisXu Yingkai, Jiang Jianfeng, Hu Zhiyong, et al.
Discover Oncology|February 13, 2026
Synthetic lethality and DNA damage response targeting in cancer stem cells: a comprehensive reviewUsamah Sayed, Waleed K Abdulsahib, Ihsan Khudhair Jasim, et al.
Discover Oncology|February 12, 2026
Integrated analysis of glutamine metabolism and immune microenvironment identifies GOT2 as a prognostic gene in head and neck squamous cell carcinomaXikong Pan, Tingbo Ye, Jianjun Liu, et al.
Discover Oncology|November 3, 2025
FAM3B overexpression correlates with poor prognosis and immune dysregulation in colorectal cancer: insights from bioinformatics and Mendelian randomization analysesPeng Huang, Pei Li, Chengshuo Zhang, et al.
Discover Oncology|November 3, 2025
Elucidating the role of SIRT2 in hepatocellular carcinoma through multi-omics and deep learningChangan Chen, Tingmei Yang, Caiyuan Yu, et al.
Pageof 421